Cargando…

Human Islet Amyloid Polypeptide (hIAPP) Protofibril‐Specific Antibodies for Detection and Treatment of Type 2 Diabetes

Type 2 diabetes mellitus (T2D) is a major public health concern and is characterized by sustained hyperglycemia due to insulin resistance and destruction of insulin‐producing β cells. One pathological hallmark of T2D is the toxic accumulation of human islet amyloid polypeptide (hIAPP) aggregates. Mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bortoletto, Angelina S., Graham, W. Vallen, Trout, Gabriella, Bonito‐Oliva, Alessandra, Kazmi, Manija A., Gong, Jing, Weyburne, Emily, Houser, Brandy L., Sakmar, Thomas P., Parchem, Ronald J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731688/ https://www.ncbi.nlm.nih.gov/pubmed/36257905 http://dx.doi.org/10.1002/advs.202202342

Ejemplares similares

Human Islet Amyloid Polypeptide (hIAPP) Protofibril‐Specific Antibodies for Detection and Treatment of Type 2 Diabetes (Adv. Sci. 34/2022)
por: Bortoletto, Angelina S., et al.
Publicado: (2022)

Conformationally restricted short peptides inhibit human islet amyloid polypeptide (hIAPP) fibrillization
por: Mishra, Aseem, et al.
Publicado: (2013)

β-Hairpin Peptide Mimics Decrease Human Islet Amyloid Polypeptide (hIAPP) Aggregation
por: Lesma, Jacopo, et al.
Publicado: (2021)

Epigallocatechin gallate (EGCG) reduces the intensity of pancreatic amyloid fibrils in human islet amyloid polypeptide (hIAPP) transgenic mice
por: Franko, Andras, et al.
Publicado: (2018)

Adsorption and Orientation of Human Islet Amyloid Polypeptide (hIAPP) Monomer at Anionic Lipid Bilayers: Implications for Membrane-Mediated Aggregation
por: Jia, Yan, et al.
Publicado: (2013)

Bleomycin modulates amyloid aggregation in β-amyloid and hIAPP
por: Kumari, Anchala, et al.
Publicado: (2020)

Conformation‐specific antibodies against multiple amyloid protofibril species from a single amyloid immunogen
por: Bonito‐Oliva, Alessandra, et al.
Publicado: (2019)

Human Islet Amyloid Polypeptide Transgenic Mice: In Vivo and Ex Vivo Models for the Role of hIAPP in Type 2 Diabetes Mellitus
por: Höppener, J. W. M., et al.
Publicado: (2008)

A pancreatic player in dementia: pathological role for islet amyloid polypeptide accumulation in the brain
por: Bortoletto, Angelina S., et al.
Publicado: (2023)

Myricetin Inhibits Islet Amyloid Polypeptide (IAPP) Aggregation and Rescues Living Mammalian Cells from IAPP Toxicity
por: Zelus, Casey, et al.
Publicado: (2012)

Conformational Ensemble of hIAPP Dimer: Insight into the Molecular Mechanism by which a Green Tea Extract inhibits hIAPP Aggregation
por: Mo, Yuxiang, et al.
Publicado: (2016)

Tuning the rate of aggregation of hIAPP into amyloid using small-molecule modulators of assembly
por: Xu, Yong, et al.
Publicado: (2022)

Effect of DNA Origami Nanostructures on hIAPP Aggregation
por: Hanke, Marcel, et al.
Publicado: (2020)

A Novel Pentapeptide Inhibitor Reduces Amyloid Deposit Formation by Direct Interaction with hIAPP
por: Shi, Yue, et al.
Publicado: (2019)

Exploring the Influence of EGCG on the β-Sheet-Rich Oligomers of Human Islet Amyloid Polypeptide (hIAPP(1–37)) and Identifying Its Possible Binding Sites from Molecular Dynamics Simulation
por: Wang, Qianqian, et al.
Publicado: (2014)

Diabetes Drug Discovery: hIAPP(1–37) Polymorphic Amyloid Structures as Novel Therapeutic Targets
por: Fernández-Gómez, Isaac, et al.
Publicado: (2018)

Chitosan Oligosaccharides Attenuate Amyloid Formation of hIAPP and Protect Pancreatic β-Cells from Cytotoxicity
por: Meng, Qin-Yu, et al.
Publicado: (2020)

Effect of Terminal Modifications on the Adsorption and Assembly of hIAPP(20–29)
por: Hajiraissi, Roozbeh, et al.
Publicado: (2019)

Factors That Contribute to hIAPP Amyloidosis in Type 2 Diabetes Mellitus
por: Sevcuka, Adriana, et al.
Publicado: (2022)

Characterisation of the Structure and Oligomerisation of Islet Amyloid Polypeptides (IAPP): A Review of Molecular Dynamics Simulation Studies
por: Moore, Sandra J., et al.
Publicado: (2018)

Nucleobindin 1 binds to multiple types of pre-fibrillar amyloid and inhibits fibrillization
por: Bonito-Oliva, Alessandra, et al.
Publicado: (2017)

Stabilization and structural analysis of a membrane-associated hIAPP aggregation intermediate
por: Rodriguez Camargo, Diana C, et al.
Publicado: (2017)

Expression of wild‐type and mutant S20G hIAPP in physiologic knock‐in mouse models fails to induce islet amyloid formation, but induces mild glucose intolerance
por: Hiddinga, Henry J, et al.
Publicado: (2011)

Unfolding Novel Mechanisms of Polyphenol Flavonoids for Better Glycaemic Control: Targeting Pancreatic Islet Amyloid Polypeptide (IAPP)
por: Sequeira, Ivana R., et al.
Publicado: (2017)

Pancreatic β cells overexpressing hIAPP impaired mitophagy and unbalanced mitochondrial dynamics
por: Hernández, Miriam García, et al.
Publicado: (2018)

The redox environment triggers conformational changes and aggregation of hIAPP in Type II Diabetes
por: Rodriguez Camargo, Diana C., et al.
Publicado: (2017)

Nanoscale Surface Topography Modulates hIAPP Aggregation Pathways at Solid–Liquid Interfaces
por: Hanke, Marcel, et al.
Publicado: (2021)

The Effect of Calcium Ions on hIAPP Channel Activity: Possible Implications in T2DM
por: Meleleo, Daniela, et al.
Publicado: (2023)

The Human Host‐Defense Peptide Cathelicidin LL‐37 is a Nanomolar Inhibitor of Amyloid Self‐Assembly of Islet Amyloid Polypeptide (IAPP)
por: Armiento, Valentina, et al.
Publicado: (2020)

Tryptophan-galactosylamine conjugates inhibit and disaggregate amyloid fibrils of Aβ42 and hIAPP peptides while reducing their toxicity
por: Paul, Ashim, et al.
Publicado: (2020)

Protein-conformational diseases in childhood: Naturally-occurring hIAPP amyloid-oligomers and early β-cell damage in obesity and diabetes
por: Altamirano-Bustamante, Nelly F., et al.
Publicado: (2020)

BRICHOS domain of Bri2 inhibits islet amyloid polypeptide (IAPP) fibril formation and toxicity in human beta cells
por: Oskarsson, Marie E., et al.
Publicado: (2018)

Linking hIAPP misfolding and aggregation with type 2 diabetes mellitus: a structural perspective
por: Hassan, Shahab, et al.
Publicado: (2022)

Atomic structures of fibrillar segments of hIAPP suggest tightly mated β-sheets are important for cytotoxicity
por: Krotee, Pascal, et al.
Publicado: (2017)

Metastable intermediate during hIAPP aggregation catalyzed by membranes as detected with 2D IR spectroscopy
por: Dicke, Sidney S., et al.
Publicado: (2022)

Unpacking the aggregation-oligomerization-fibrillization process of naturally-occurring hIAPP amyloid oligomers isolated directly from sera of children with obesity or diabetes mellitus
por: Altamirano-Bustamante, Myriam M., et al.
Publicado: (2019)

Active Immunization Against hIAPP Oligomers Ameliorates the Diabetes- Associated Phenotype in a Transgenic Mice Model
por: Bram, Yaron, et al.
Publicado: (2017)

High-Fat Diet Increases Amylin Accumulation in the Hippocampus and Accelerates Brain Aging in hIAPP Transgenic Mice
por: Xi, Xiao-Xia, et al.
Publicado: (2019)

Structural Similarities and Differences between Amyloidogenic and Non-Amyloidogenic Islet Amyloid Polypeptide (IAPP) Sequences and Implications for the Dual Physiological and Pathological Activities of These Peptides
por: Wu, Chun, et al.
Publicado: (2013)

Site-specific single point mutation by anthranilic acid in hIAPP(8–37) enhances anti-amyloidogenic activity
por: Kalita, Sourav, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i8k9e1el6kou8s59c1fo7hq2ik